14.40
-0.54 (-3.61%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Bearish |
| Medical Devices (Global) | Bearish | Bearish | |
| Stock | Quanterix Corporation | Bearish | - |
Stockmoo Score
|
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew – Custom Assay Development, and Uman NF-Light. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Ashford Capital Management Inc | 31 Mar 2024 | 831,535 |
| Emerald Advisers, Llc | 31 Mar 2024 | 705,447 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 25.00 (Canaccord Genuity, 73.61%) | Buy |
| Median | 24.50 (70.14%) | |
| Low | 24.00 (Goldman Sachs, 66.67%) | Buy |
| Average | 24.50 (70.14%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 14.12 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Goldman Sachs | 09 Jul 2024 | 24.00 (66.67%) | Buy | 12.65 |
| Canaccord Genuity | 29 Apr 2024 | 25.00 (73.61%) | Buy | 15.58 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| TOLOUE MASOUD | - | 15.08 | -1,120 | -16,890 |
| Aggregate Net Quantity | -1,120 | |||
| Aggregate Net Value ($) | -16,890 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 15.08 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| TOLOUE MASOUD | Officer | 15 Jul 2024 | Disposed (-) | 1,120 | 15.08 | 16,890 |
| Date | Type | Details |
|---|---|---|
| 17 Jun 2024 | Announcement | Quanterix to Participate at the Scotiabank Healthcare 1x1 Day |
| 05 Jun 2024 | Announcement | Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference |
| 22 May 2024 | Announcement | Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024 |
| 07 May 2024 | Announcement | Quanterix Releases Financial Results for the First Quarter of 2024 |
| 29 Apr 2024 | Announcement | Quanterix To Report First Quarter 2024 Financial Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |